Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family
about
The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritisThe ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase BDeletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemiaThe roles of TTP and BRF proteins in regulated mRNA decayThe control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatasesZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF productionBRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sitesTTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elementsRecruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11bCharacterization of DeltaN-Zfp36l2 mutant associated with arrest of early embryonic development and female infertilityDifferential expression and functional analysis of the tristetraprolin family during early differentiation of 3T3-L1 preadipocytesZfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteinsDefects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65A unique C-terminal repeat domain maintains the cytosolic localization of the placenta-specific tristetraprolin family member ZFP36L3Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinaseEmergence and evolution of Zfp36l3Deficiency of the placenta- and yolk sac-specific tristetraprolin family member ZFP36L3 identifies likely mRNA targets and an unexpected link to placental iron metabolismIdentification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesisPhosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin.Zinc finger protein ZFP36L1 promotes osteoblastic differentiation but represses adipogenic differentiation of mouse multipotent cellsMyeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infectionUnder the Tucson sun: a meeting in the desert on mRNA decay.Mid-gestational gene expression profile in placenta and link to pregnancy complications.ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.Comparative functional analysis of ZFP36 genes during Xenopus development.The Drosophila Tis11 protein and its effects on mRNA expression in flies.NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.hnRNP F complexes with tristetraprolin and stimulates ARE-mRNA decay.Regulation of pluripotency by RNA binding proteinsNovel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.Probing the structural and dynamical effects of the charged residues of the TZF domain of TIS11d.Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats.Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophagesDirect binding of specific AUF1 isoforms to tandem zinc finger domains of tristetraprolin (TTP) family proteins.Drosophila eyes absent is a novel mRNA target of the tristetraprolin (TTP) protein DTIS11Genomic profiling screens small molecules of metastatic prostate carcinoma.cAMP stimulation of StAR expression and cholesterol metabolism is modulated by co-expression of labile suppressors of transcription and mRNA turnoverDevelopment of structures and transport functions in the mouse placenta.Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.
P2860
Q21195674-AEDD670B-2AA4-419E-BC2A-FAA0938BFD9EQ24558903-95D718A7-4E93-4B9E-881B-BECA15F1CA12Q24632890-53ACC687-BDBE-4E98-B9A7-E870FF79ACD3Q24633013-12D9E84E-FEA0-43A8-8274-EF0BFA64D5AFQ28076811-2D9574FE-ACF8-4C69-B204-7A15E273A0FBQ28115802-C1CC0205-C39F-4070-8A0B-A4F56334B960Q28117267-1A4828EB-622C-4181-B153-1BC2D36F556FQ28117692-618E0978-B567-4C20-AAAD-EF16976FCAE0Q28118675-806A36F2-4A25-4E15-8DB1-EF10AF165D75Q28118974-72BDF043-9A3C-4635-8EAA-FFE3E0E676F4Q28505231-97EDBBF5-8A06-4FFB-A376-0357D22FBE76Q28505723-5451EE3C-D684-4D98-9CDD-F22E956FE8E1Q28512063-8524FC96-718E-4BE1-8DFA-58996406D697Q28512949-449DF9C5-CA21-4C0C-93C7-87A704AF0121Q28588846-AEB98138-88E3-4656-A139-06C50148BDACQ28589341-F3C00C26-651D-40D5-B233-315F6E52EFD8Q28606995-864FBAE7-BB39-445D-8722-480FE8F8B339Q30353214-12C59E1B-BE97-42D8-95CB-BBFD2554B70DQ33226407-506B2287-8941-4C85-AAE7-1700BFA99613Q33309340-2171BEE5-02D5-49FE-8730-3B888CBA2E05Q33591250-E2C8EE7E-3F59-4796-9CC9-9AF7C5138F87Q34316013-526299F7-E96B-4B82-BFBA-CA72A16D1345Q34366114-CC717AD1-B993-4F9A-8459-936B57519A9AQ34474307-CA302BB9-AD1D-4312-A83E-CC0CC19745A4Q34533271-78D15B46-CE71-44E0-ACA5-318FC828B8C2Q34559527-10236BB2-7C60-41C5-AE99-F0D7B84628DBQ34737692-70AE0F8D-C6EA-4C9D-86AF-2536DB0BB8DCQ35006266-65ACC1BC-422D-478A-A269-7019E773CC17Q35197924-2C754BCE-B7E6-4CB7-8551-D8C25F314FA0Q35213434-F9BB1E23-4885-4F8C-9DDE-564697B0AAEEQ35221409-8189D754-482D-4829-B5CA-85258AE6CA80Q35221436-90A99E14-30DF-49B0-A4D2-5FAA52760C84Q35613550-F900C3B9-B841-4100-85A5-7AA88A2676C5Q35852391-4EED8066-3B76-496A-B1A2-E9854819017CQ35886854-FB0597CB-5A8C-4D0B-87D5-5630733EE094Q35926324-397FE9FA-15CB-43C2-919A-8786FE3A4D18Q35944324-AECF1177-E8CC-45FA-8635-612EC15054CAQ36114612-47796F4F-DF73-473D-B008-EB741A12E3C9Q36124326-438DD693-06FD-47F6-B5AC-BCA8CD1316ACQ36431066-A062379C-869F-4AFB-B670-C21F66993FA9
P2860
Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/07/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/07/01)
@nl
наукова стаття, опублікована в липні 2004
@uk
مقالة علمية (نشرت في يوليو 2004)
@ar
name
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@ast
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@en
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@nl
type
label
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@ast
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@en
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@nl
prefLabel
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@ast
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@en
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@nl
P2093
P2860
P3181
P1476
Chorioallantoic fusion defects ...... of the Tristetraprolin family
@en
P2093
Deborah J. Stumpo
Erik N. Meyers
Noah A. Byrd
Perry J. Blackshear
Robert R. Maronpot
Ruth S. Phillips
Sanjukta Ghosh
Trisha Castranio
Yuji Mishina
P2860
P304
P3181
P356
10.1128/MCB.24.14.6445-6455.2004
P407
P577
2004-07-01T00:00:00Z